Literature DB >> 10531222

Interaction of Mycobacterium tuberculosis-induced transforming growth factor beta1 and interleukin-10.

C Othieno1, C S Hirsch, B D Hamilton, K Wilkinson, J J Ellner, Z Toossi.   

Abstract

Mycobacterium tuberculosis is associated with the activation of cytokine circuits both at sites of active tuberculosis in vivo and in cultures of mononuclear cells stimulated by M. tuberculosis or its components in vitro. Interactive stimulatory and/or inhibitory pathways are established between cytokines, which may result in potentiation or attenuation of the effects of each molecule on T-cell responses. Here we examined the interaction of transforming growth factor beta1 (TGF-beta1) and interleukin-10 (IL-10) in purified protein derivative (PPD)-stimulated human mononuclear cell cultures in vitro. TGF-beta1 induced monocyte IL-10 (but not tumor necrosis factor alpha) production (by 70-fold, P < 0.02) and mRNA expression in the absence but not in the presence of PPD. Both exogenous recombinant (r) IL-10 and rTGF-beta1 independently suppressed the production of PPD-induced gamma interferon (IFN-gamma) in mononuclear cells from PPD skin test-positive individuals. Synergistic suppression of IFN-gamma in cultures containing both rTGF-beta1 and rIL-10 was only seen when the responder cell population were peripheral blood mononuclear cells (PBMC) and not monocyte-depleted mononuclear cells and when PBMC were pretreated with rTGF-beta1 but not with rIL-10. Suppression of PPD-induced IFN-gamma in PBMC containing both rTGF-beta1 (1 ng/ml) and rIL-10 (100 pg/ml) was 1.5-fold higher (P < 0.05) than cultures containing TGF-beta1 alone and 5.7-fold higher (P < 0.004) than cultures containing IL-10 alone. Also, neutralization of endogenous TGF-beta1 and IL-10 together enhanced PPD-induced IFN-gamma in PBMC in a synergistic manner. Thus, TGF-beta1 and IL-10 together potentiate the downmodulatory effect on M. tuberculosis-induced T-cell production of IFN-gamma, and TGF-beta1 alone enhances IL-10 production. At sites of active M. tuberculosis infection, these interactions may be conducive to the suppression of mononuclear cell functions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10531222      PMCID: PMC96948     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity.

Authors:  I P Oswald; R T Gazzinelli; A Sher; S L James
Journal:  J Immunol       Date:  1992-06-01       Impact factor: 5.422

2.  IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function.

Authors:  L Ding; E M Shevach
Journal:  J Immunol       Date:  1992-05-15       Impact factor: 5.422

Review 3.  Macrophage production of TGF-beta and regulation by TGF-beta.

Authors:  S M Wahl; N McCartney-Francis; J B Allen; E B Dougherty; S F Dougherty
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

4.  Expression of functional interleukin 2 receptors by peripheral blood monocytes from patients with active pulmonary tuberculosis.

Authors:  Z Toossi; J R Sedor; J P Lapurga; R J Ondash; J J Ellner
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

Review 5.  Review: the immune response in human tuberculosis--implications for tuberculosis control.

Authors:  J J Ellner
Journal:  J Infect Dis       Date:  1997-11       Impact factor: 5.226

6.  Isolation of leucocytes from human blood. A two-phase system for removal of red cells with methylcellulose as erythrocyte-aggregating agent.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

7.  Transforming growth factor-beta 1 modulates the expression of class II histocompatibility antigens on human cells.

Authors:  C W Czarniecki; H H Chiu; G H Wong; S M McCabe; M A Palladino
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

Review 8.  Transforming growth factor beta (TGF-beta) in inflammation: a cause and a cure.

Authors:  S M Wahl
Journal:  J Clin Immunol       Date:  1992-03       Impact factor: 8.317

9.  Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.

Authors:  R de Waal Malefyt; J Haanen; H Spits; M G Roncarolo; A te Velde; C Figdor; K Johnson; R Kastelein; H Yssel; J E de Vries
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

10.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.

Authors:  R de Waal Malefyt; J Abrams; B Bennett; C G Figdor; J E de Vries
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

View more
  31 in total

1.  Profiles of IFN-gamma and its regulatory cytokines (IL-12, IL-18 and IL-10) in peripheral blood mononuclear cells from patients with multidrug-resistant tuberculosis.

Authors:  J-S Lee; C-H Song; C-H Kim; S-J Kong; M-H Shon; H-J Kim; J-K Park; T-H Paik; E-K Jo
Journal:  Clin Exp Immunol       Date:  2002-06       Impact factor: 4.330

2.  Interleukin-10 induces inhibitory C/EBPbeta through STAT-3 and represses HIV-1 transcription in macrophages.

Authors:  Naohiko Tanaka; Yoshihiko Hoshino; Jeffrey Gold; Satomi Hoshino; Frank Martiniuk; Takeshi Kurata; Richard Pine; David Levy; William N Rom; Michael Weiden
Journal:  Am J Respir Cell Mol Biol       Date:  2005-07-13       Impact factor: 6.914

3.  Intestinal helminth co-infection has a negative impact on both anti-Mycobacterium tuberculosis immunity and clinical response to tuberculosis therapy.

Authors:  T Resende Co; C S Hirsch; Z Toossi; R Dietze; R Ribeiro-Rodrigues
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

Review 4.  Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease.

Authors:  Shankar Subramanian Iyer; Gehong Cheng
Journal:  Crit Rev Immunol       Date:  2012       Impact factor: 2.214

5.  Up-regulation of Th1-type responses in mucosal leishmaniasis patients.

Authors:  Olívia Bacellar; Hélio Lessa; Albert Schriefer; Paulo Machado; Amélia Ribeiro de Jesus; Walderez O Dutra; Kenneth J Gollob; Edgar M Carvalho
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

6.  Transgenic mice expressing human interleukin-10 in the antigen-presenting cell compartment show increased susceptibility to infection with Mycobacterium avium associated with decreased macrophage effector function and apoptosis.

Authors:  Carl G Feng; Marika C Kullberg; Dragana Jankovic; Allen W Cheever; Patricia Caspar; Robert L Coffman; Alan Sher
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

Review 7.  Biomimetic strategies based on viruses and bacteria for the development of immune evasive biomaterials.

Authors:  Matthew T Novak; James D Bryers; William M Reichert
Journal:  Biomaterials       Date:  2009-01-29       Impact factor: 12.479

8.  Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TGF-beta receptors I and II in active tuberculosis.

Authors:  M Glória Bonecini-Almeida; John L Ho; Neio Boéchat; Richard C Huard; Sadhana Chitale; Howard Doo; Jiayuan Geng; Lorena Rego; Luiz Claudio Oliveira Lazzarini; Afrânio L Kritski; Warren D Johnson; Timothy A McCaffrey; José R Lapa e Silva
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

9.  The Mycobacterium tuberculosis complex-restricted gene cfp32 encodes an expressed protein that is detectable in tuberculosis patients and is positively correlated with pulmonary interleukin-10.

Authors:  Richard C Huard; Sadhana Chitale; Mary Leung; Luiz Claudio Oliveira Lazzarini; Hongxia Zhu; Elena Shashkina; Suman Laal; Marcus B Conde; Afrânio L Kritski; John T Belisle; Barry N Kreiswirth; José Roberto Lapa e Silva; John L Ho
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

10.  Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-beta1.

Authors:  Helen A Fletcher; Ansar A Pathan; Tamara K Berthoud; Susanna J Dunachie; Kathryn T Whelan; Nicola C Alder; Clare R Sander; Adrian V S Hill; Helen McShane
Journal:  Vaccine       Date:  2008-08-03       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.